LMAT Stock Analysis: Buy, Sell, or Hold?
LMAT - LeMaitre Vascular, Inc.
$97.31
-2.19 (-2.20%)
▼
5d:
-9.85%
30d:
-12.84%
90d:
+11.01%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Smart Money Accumulation
LMAT is down 8.8% this week, but smart money is accumulating calls. Top strike: $90 2026-06-18 with 4 OI. Call ratio: 64% View Scanner →
Strength: 5.8/10
Get Alerted When LMAT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LMAT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: LMAT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$110.15
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$68.39
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LMAT is currently trading at $97.31, which is considered oversold relative to its 30-day fair value range of $104.06 to $115.66. From a valuation perspective, the stock is trading at a discount (Forward PE: 29.9) compared to its historical average (33.9). Remarkably, the market is currently pricing in an annual earnings decline of 4.1% over the next few years. This pessimistic expectation contrasts with the company's recent 41.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, LMAT is in a strong uptrend. The price is currently testing key support at $95.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LMAT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $118.75 (+22.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LMAT is in a strong uptrend. The price is currently testing key support at $95.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LMAT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $118.75 (+22.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$104.06 -
$115.66
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.4%
Protect Your Profits
Holding LMAT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.0% below Wall St target ($118.75)
- CAUTION: Recommendation downgraded due to -9.8% 5-day decline
Trading Range Analysis
30-Day Trading Range
$104.06 -
$115.66
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$3.83
(3.9%)
Support & Resistance Levels
Support Level
$95.46
Resistance Level
$115.75
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
29.89
Wall Street Target
$118.75
(+22.0%)
Revenue Growth (YoY)
11.2%
Earnings Growth (YoY)
41.7%
Profit Margin
24.3%
Valuation Discount vs History
-4.1% cheaper
PE vs Historical
29.9 vs 33.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.1%
(market-implied from PE analysis)
1-Year Target
$93.32
(-4%)
2-Year Target
$89.49
(-8%)
3-Year Target
$85.82
(-12%)
3-Yr Target (if PE normalizes)
(PE: 30→34)
$97.34
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 29.9, Growth: 8.5%)
$124.36
(+28%)
Base:
(SPY PE: 22.1, Growth: 8.5%)
$91.83
(-6%)
Bear:
(PE: 18.8, Growth: 8.5%)
$78.05
(-20%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (37x PE), but valuation improves significantly next year (30x PE) as earnings recover.
Trailing PE: 36.58 | Current EPS (TTM): $2.72
Bull Case
$131.00
(+35%)
Analyst growth 19.7%, PE expands to 40.2
Base Case
$119.09
(+22%)
Market implied 19.7%, PE stable at 36.6
Bear Case
$67.66
(-31%)
Severe decline -20.0%, PE contracts to 31.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 29.9 to 33.9
Stabilization Target:
$110.36
(+13.4%)
PE Expansion Potential:
+13.4%
Share & Embed Analysis
Last updated: May 18, 2026 1:23 AM ET
Data refreshes hourly during market hours. Next update: 2:23 AM
Data refreshes hourly during market hours. Next update: 2:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LMAT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
George W Lemaitre
SELL
55930 shares
2026-03-02
David B Roberts
SELL
8464 shares
2026-02-27
Trent G Kamke
SELL
1044 shares
2026-02-27
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$577 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 53 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$271 | 59 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$179 | 49 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$91 | 64 BUY |
Advanced LMAT Option Strategies
Professional options setups generated by AI based on today's LMAT price and gamma walls.
